RGBP News and Press, Regen BioPharma Inc From 07/27/22

The shares of nanocap biotech Regen BioPharma ( OTCPK:RGBP ) surged 21% on Wednesday to reach the highest level since May after the company announced the submission of a U.S. patent application related to a mRNA cancer immunotherapeutic vaccine. The provisional patent appl...

Regen BioPharma, Inc. Files Provisional Patent Application on Second Generation Survivin mRNA Cancer Immunotherapy Vaccine PR Newswire Novel Means of Leveraging Cellular Therapy to "Teach" Immune System to Seek and Destroy Cancer SAN DIEGO , July 26, ...

Regen BioPharma, Inc. Responds to Numerous Requests for Updates on its Intellectual Property (IP) Portfolio PR Newswire SAN DIEGO , March 16, 2022 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) has an extensive intellectual property port...

Regen BioPharma, Inc. Announces Program to Fast-Track its Checkpoint Inhibitor Program Utilizing Modified mRNA and siRNA Technologies PR Newswire SAN DIEGO , March 10, 2022 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) announced a progr...

SAN FRANCISCO, CA / ACCESSWIRE / February 14, 2022 / Oncology Pharma, Inc. ("The Company") (OTC PINK:ONPH) and Regen BioPharma, Inc. (OTC PINK:RGBP) and (OTC PINK:RGBPP): announced that they intend to work jointly to fast track the development of therapeutic uses related to treatment in huma...

Regen BioPharma (OTCPK:RGBP) is beginning a development program to commercialize its modified mRNA anti-cancer vaccine targeting the Survivin protein. In the first phase, Regen will design and carry out experiments which will form the initial series of pre-clinical studies required as part of...

Regen BioPharma, Inc. to Initiate Development of its Modified mRNA anti-Cancer Vaccine Technology PR Newswire SAN DIEGO , Feb. 11, 2022 /PRNewswire/ -- Regen BioPharma, Inc. (PINK: RGBP) and (PINK: RGBPP) is embarking on a development program to commercializ...

REGEN BIOPHARMA, INC.: MESSAGE TO THE SHAREHOLDERS FROM THE CHAIRMAN AND CHIEF EXECUTIVE OFFICER PR Newswire SAN DIEGO , Dec. 30, 2021 /PRNewswire/ -- Regen BioPharma, Inc. (PINK: RGBP) and (PINK: RGBPP): First of all I would like to wish all our sharehol...

Regen BioPharma, Inc. Announces Signing of a Letter of Intent to Acquire an In vitro Diagnostics Start-Up Company Canary Oncoceutics, Inc. Which is Developing Functional Cancer Tests for Personalized Medicine PR Newswire SAN DIEGO , Nov. 17, 2021 /PRNewswire/ --&...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Little-known penny stock  Regen Biopharma (OTCMKTS: RGBP ) has soared 800% at the time of writing. That’s not a typo. Investors in RGBP stock have booked an 8-bagger in this stock today as the company anno...